1 序文
2 調査範囲と方法論
2.1 調査の目的
2.2 ステークホルダー
2.3 データソース
2.3.1 一次情報源
2.3.2 二次情報源
2.4 市場推定
2.4.1 ボトムアップアプローチ
2.4.2 トップダウンアプローチ
2.5 予測方法
3 エグゼクティブ・サマリー
4 はじめに
4.1 概要
4.2 主要産業動向
5 世界のヌクレオチド市場
5.1 市場概要
5.2 市場パフォーマンス
5.3 COVID-19の影響
5.4 市場予測
6 種類別市場構成
6.1 食品グレード
6.1.1 市場動向
6.1.2 市場予測
6.2 ラボグレード
6.2.1 市場動向
6.2.2 市場予測
6.3 インダストリーグレード
6.3.1 市場動向
6.3.2 市場予測
6.4 その他
6.4.1 市場動向
6.4.2 市場予測
7 技術別市場内訳
7.1 TaqManアレル識別
7.1.1 市場動向
7.1.2 市場予測
7.2 遺伝子チップとマイクロアレイ
7.2.1 市場動向
7.2.2 市場予測
7.3 パイロシーケンスによるSNP
7.3.1 市場動向
7.3.2 市場予測
7.4 その他
7.4.1 市場動向
7.4.2 市場予測
8 形態別市場
8.1 液体
8.1.1 市場動向
8.1.2 市場予測
8.2 粉末
8.2.1 市場動向
8.2.2 市場予測
9 用途別市場
9.1 医薬品
9.1.1 市場動向
9.1.2 市場予測
9.2 食品・飼料添加物
9.2.1 市場動向
9.2.2 市場予測
9.3 創薬
9.3.1 市場動向
9.3.2 市場予測
9.4 その他
9.4.1 市場動向
9.4.2 市場予測
10 地域別市場内訳
10.1 北米
10.1.1 米国
10.1.1.1 市場動向
10.1.1.2 市場予測
10.1.2 カナダ
10.1.2.1 市場動向
10.1.2.2 市場予測
10.2 アジア太平洋
10.2.1 中国
10.2.1.1 市場動向
10.2.1.2 市場予測
10.2.2 日本
10.2.2.1 市場動向
10.2.2.2 市場予測
10.2.3 インド
10.2.3.1 市場動向
10.2.3.2 市場予測
10.2.4 韓国
10.2.4.1 市場動向
10.2.4.2 市場予測
10.2.5 オーストラリア
10.2.5.1 市場動向
10.2.5.2 市場予測
10.2.6 インドネシア
10.2.6.1 市場動向
10.2.6.2 市場予測
10.2.7 その他
10.2.7.1 市場動向
10.2.7.2 市場予測
10.3 ヨーロッパ
10.3.1 ドイツ
10.3.1.1 市場動向
10.3.1.2 市場予測
10.3.2 フランス
10.3.2.1 市場動向
10.3.2.2 市場予測
10.3.3 イギリス
10.3.3.1 市場動向
10.3.3.2 市場予測
10.3.4 イタリア
10.3.4.1 市場動向
10.3.4.2 市場予測
10.3.5 スペイン
10.3.5.1 市場動向
10.3.5.2 市場予測
10.3.6 ロシア
10.3.6.1 市場動向
10.3.6.2 市場予測
10.3.7 その他
10.3.7.1 市場動向
10.3.7.2 市場予測
10.4 中南米
10.4.1 ブラジル
10.4.1.1 市場動向
10.4.1.2 市場予測
10.4.2 メキシコ
10.4.2.1 市場動向
10.4.2.2 市場予測
10.4.3 その他
10.4.3.1 市場動向
10.4.3.2 市場予測
10.5 中東・アフリカ
10.5.1 市場動向
10.5.2 国別市場内訳
10.5.3 市場予測
11 SWOT分析
11.1 概要
11.2 長所
11.3 弱点
11.4 機会
11.5 脅威
12 バリューチェーン分析
13 ポーターズファイブフォース分析
13.1 概要
13.2 買い手の交渉力
13.3 供給者の交渉力
13.4 競争の程度
13.5 新規参入の脅威
13.6 代替品の脅威
14 価格分析
15 競争環境
15.1 市場構造
15.2 主要プレーヤー
15.3 主要プレーヤーのプロフィール
CJ CheilJedang Corporation
Exotic Biosolutions
F. Hoffmann-La Roche AG
Jena Bioscience GmbH
Koninklijke DSM N.V.
Lallemand Inc.
Meridian Bioscience Inc.
Nanjing Biotogether Co. Ltd.
Ohly GmbH （Associated British Foods plc）
Promega Corporation
Starlake Bioscience Co. Inc.
Thermo Fisher Scientific Inc.
Nucleotides are the basic building block of nucleic acids, such as ribonucleic acid (RNA) and deoxyribonucleic acid (DNA). They enhance various metabolic processes and the formation of the structure of proteins synthesized in the cell. They act with enzymes to speed up biochemical reactions in the body. They also aid in the biosynthesis of macromolecules and cell signaling through interaction with purinergic receptors. In addition, nucleotides assist in encoding, transmitting, and expressing genetic information in the body. As they provide a high degree of potency and selectivity against the herpes group of viruses, nucleotides are used as antiviral or anticancer agents in several medicines.
Nucleotides Market Trends:
At present, there is a rise in the utilization of nucleotide supplements in dairy products, such as yogurt and condensed and powdered milk, across the globe. This, along with the growing availability of these supplements in the form of powdered fluids, represents one of the key factors driving the market. Besides this, the increasing employment of nucleotides in nutraceuticals to treat conditions, such as poor nutrition, stress, and hypertension, is contributing to the growth of the market. In addition, the rising application of nucleotides in diagnostic research to diagnose the presence of various viral diseases and types of cancer is propelling the growth of the market. Moreover, there is an increase in the demand for nucleotides in animal feed to maintain metabolism rates in livestock. This, coupled with the growing awareness among the masses about the harmful impacts of animal diseases, is positively influencing the market. Apart from this, the escalating demand for nucleotides to enhance the recovery of intestinal epithelial cells, which helps boost the immunity system, is offering a positive market outlook. Additionally, the increasing usage of ribonucleotides in infant food formulations is bolstering the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global nucleotides market report, along with forecasts at the global, regional and country level from 2025-2033. Our report has categorized the market based on type, technology, form and application.
Breakup by Type:
Food Grade
Lab Grade
Industry Grade
Others
Breakup by Technology:
TaqMan Allelic Discrimination
Gene Chips and Microarrays
SNP by Pyrosequencing
Others
Breakup by Form:
Liquid
Powder
Breakup by Application:
Pharmaceutical
Food and Animal Feed Additives
Drug Discovery
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being CJ CheilJedang Corporation, Exotic Biosolutions, F. Hoffmann-La Roche AG, Jena Bioscience GmbH, Koninklijke DSM N.V., Lallemand Inc., Meridian Bioscience Inc., Nanjing Biotogether Co. Ltd., Ohly GmbH (Associated British Foods plc), Promega Corporation, Starlake Bioscience Co. Inc. and Thermo Fisher Scientific Inc. Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report
How has the global nucleotides market performed so far, and how will it perform in the coming years?
What has been the impact of COVID-19 on the global nucleotides market?
What are the key regional markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the technology?
What is the breakup of the market based on the form?
What is the breakup of the market based on the application?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global nucleotides market, and who are the key players?
What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Nucleotides Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Food Grade
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Lab Grade
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Industry Grade
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Technology
7.1 TaqMan Allelic Discrimination
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Gene Chips and Microarrays
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 SNP by Pyrosequencing
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by Form
8.1 Liquid
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Powder
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by Application
9.1 Pharmaceutical
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Food and Animal Feed Additives
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Drug Discovery
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 CJ CheilJedang Corporation
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.2 Exotic Biosolutions
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 F. Hoffmann-La Roche AG
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.4 Jena Bioscience GmbH
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.5 Koninklijke DSM N.V.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 Lallemand Inc.
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 Meridian Bioscience Inc.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Nanjing Biotogether Co. Ltd.
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.9 Ohly GmbH (Associated British Foods plc)
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.10 Promega Corporation
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.11 Starlake Bioscience Co. Inc.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.12 Thermo Fisher Scientific Inc.
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis
*** ヌクレオチドの世界市場に関するよくある質問(FAQ) ***
・ヌクレオチドの世界市場規模は？
→IMARC社は2024年のヌクレオチドの世界市場規模を7億6270万米ドルと推定しています。
・ヌクレオチドの世界市場予測は？
→IMARC社は2033年のヌクレオチドの世界市場規模を1,288.3百万米ドルと予測しています。
・ヌクレオチド市場の成長率は？
→IMARC社はヌクレオチドの世界市場が2025年～2033年に年平均6.0%成長すると展望しています。
・世界のヌクレオチド市場における主要プレイヤーは？
→「CJ CheilJedang Corporation、Exotic Biosolutions、F. Hoffmann-La Roche AG、Jena Bioscience GmbH、Koninklijke DSM N.V.、Lallemand Inc.、Meridian Bioscience Inc.、Nanjing Biotogether Co. Ltd.、Ohly GmbH (Associated British Foods plc)、Promega Corporation、Starlake Bioscience Co. Inc.、Thermo Fisher Scientific Inc.など ...」をヌクレオチド市場のグローバル主要プレイヤーとして判断しています。
※上記FAQの市場規模、市場予測、成長率、主要企業に関する情報は本レポートの概要を作成した時点での情報であり、最終レポートの情報と少し異なる場合があります。
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
